These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813 [TBL] [Abstract][Full Text] [Related]
5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477 [TBL] [Abstract][Full Text] [Related]
7. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro. He F; Bai J; Wang J; Zhai J; Tong L; Zhu G J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022 [TBL] [Abstract][Full Text] [Related]
8. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro. Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951 [TBL] [Abstract][Full Text] [Related]
9. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro. Wu Q; Zhou X; Huang D; Ji Y; Kang F Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513 [TBL] [Abstract][Full Text] [Related]
10. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [TBL] [Abstract][Full Text] [Related]
11. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes. Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792 [TBL] [Abstract][Full Text] [Related]
12. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
13. Osteoclast differentiation by RANKL and OPG signaling pathways. Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279 [TBL] [Abstract][Full Text] [Related]
15. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
16. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. Dela Cruz A; Grynpas MD; Mitchell J Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198 [TBL] [Abstract][Full Text] [Related]
17. Effect of fluoride on osteocyte-driven osteoclastic differentiation. Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525 [TBL] [Abstract][Full Text] [Related]
18. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382 [TBL] [Abstract][Full Text] [Related]
19. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H; Härkönen PL; Väänänen HK; Hentunen TA J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275 [TBL] [Abstract][Full Text] [Related]